Roche Could Increase Supply Of Tamiflu To U.S. Market
This article was originally published in The Pink Sheet Daily
Executive Summary
The company says existing inventory of the flu therapy could be used this winter season. Roche is expecting double-digit sales growth for the year, but says investors should not expect a significant upswing in fourth quarter performance.